Methods to address functional unblinding of raters in CNS trials
Abstract Treatment-emergent adverse events (TEAEs) associated with the unique properties of a pharmaceutical product may functionally unblind clinician ratings, obscure true medication effects, and affect confidence about clinical trial results. Central nervous system studies are particularly suscep...
Saved in:
Main Authors: | Steven D. Targum, William P. Horan, Vicki G. Davis, Alan Breier, Stephen K. Brannan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-025-03262-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Point-of-Care Diagnostic Device for Traumatic Pneumothorax: Low Sensitivity of the Unblinded PneumoScan™
by: M. Rehfeldt, et al.
Published: (2018-01-01) -
The Functional Movement Screen: Exploring Interrater Reliability between Raters in the Updated Version
by: Ricky Morgan, et al.
Published: (2023-06-01) -
Item-level and Composite-level Interrater Reliability of Functional Movement Screen™ Scores Following Condensed Training in Novice Raters
by: Brent A Harper, et al.
Published: (2021-08-01) -
Assessing the Inter-Rater and Inter-Trial Reliability of the NeurOptics Pupillary Light Response-3000 Pupillometer
by: Deborah A Jehu, et al.
Published: (2025-02-01) -
Reliability of the Tuck Jump Assessment Using Standardized Rater Training
by: Kevin Racine, et al.
Published: (2021-02-01)